🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 918640103
- Market Cap
- Micro Cap
- IPO
- 8/9/2018 · $12.00/share
Business: Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders, with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease.
Company Contact
- CEO
- Maurice Zauderer, Ph.D.
- CFO
- Scott E. Royer
- Headquarters
- 1895 Mount Hope Avenue, Rochester, NY 14620
- Phone
- 585-271-2700
- Fax
- 585-271-2765
- Investor Relations
- Michael Rice, LifeSci Advisors, LLC · 646-597-6979 · rice@lifesciadvisors.com